2015冷泉港亞洲會議：腫瘤免疫及免疫療法

腫瘤免疫及免疫療法
2015年9月21日- 25日 |  蘇州獨墅湖會議酒店
http://www.csh-asia.org/2015meetings/Immune.html  

科學組委會成員:
Xuetao Cao, Chinese Academy of Medical Sciences, China
Olivera J. Finn, University of Pittsburgh, USA
Shimon Sakaguchi, Osaka University, Japan
Laurence Zitvogel, INSERM, France

會議主題：
1. Defining tumor antigens and immunogenicity
2. Vaccine-based immunotherapy
3. Immune checkpoint blockade
4. Antibody therapy
5. Adoptive T cell therapy
6. Gut microbiota, immunity and cancer
7. Inflammation, tumor microenvironment and immune escape
8. New Approaches to cancer Immunotherapy

主題演講嘉賓:
Lieping Chen, Yale University School of Medicine, USA
Abstract title:Perspectives on Anti-PD-L1/PD-1 Therapy for Advanced Human Cancers
Tadatsugu Taniguchi, University of Tokyo Institute of Industrial Science, JAPAN
Abstract title:Regulation of inflammation and anti-tumor innate immunity by self-derived molecules

特邀演講嘉賓:
Yong-Soo Bae, Sungkyunkwan University, South Korea
Abstract title:Dendritic Cell-based Tumor Immunotherapy from Bench to Bedside 
Nina Bhardwaj, Icahn School of Medicine at Mt Sinai, Tisch Cancer Institute, USA
Abstract title:Targeting innate immune cells to improve immunity. 
Subhra Biswas, A*STAR, Singapore Immunology Network, Singapore
Xuetao Cao, Chinese Academy of Medical Sciences/The Second Military Medical University, China
Olivera Finn, University of Pittsburgh School of Medicine, USA
Hiroshi Kawamoto, Kyoto University, Japan
Abstract title: Cloning and expansion of antigen specific T cells using the iPSC technology: A novel strategy for cancer immunotherapy 
Holbrook Kohrt, Stanford School of Medicine, USA
Abstract title:Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment 
Ming Li, Memorial Sloan-Kettering Cancer Center, USA
Abstract title: Immunity and Tolerance in Cancer 
Binfeng Lu, University of Pittsburgh School of Medicine, USA
Abstract title:IL-36? promotes antitumor immune responses 
Yuting Ma, Institut Gustave Roussy, France
Abstract title:STAT3 depletion enhances tumor cell immunogenicity 
Ofer Mandelboim, The Hebrew University of Jerusalem, Israel
Abstract title:Strategies used by bacteria to avoid Natural Killer cell attack 
Andreas Möller , QIMR Berghofer Medical Research Institute, Australia
Abstract title: Myeloid-Derived Suppressor Cell-mediated immune regulation at metastatic sites and pre-metastatic niches 
Michael Platten, University of Heidelberg Medical Center, Germany
Abstract title:Concepts for brain tumor vaccines 
Zhihai Qin, Institute of Biophysics, CAS, China
Abstract title:Novel Myeloid Cell Types in Tumor Microenvironment 
Michel Sadelain, Memorial Sloan Kettering Cancer Center, USA
Shimon Sakaguchi, Osaka University, Japan
Pramod Srivastava, University of Connecticut Health School of Medicine, USA
Abstract title:Define a True Tumor-Specific Epitope for Effective Cancer Immunotherapy 
Kris Thielemans, Vrije Universiteit Brussel, Belgium
Abstract title:Clinical Trials with mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma Patients 
Rongfu Wang, Houston Methodist Research Institute, USA
Laurence Zitvogel, Institut Gustave Roussy(IGR), France
Abstract title:Gut microbiota and anticancer immune responses 
Weiping Zou, University of Michigan Medical School, USA